Clinical Research Studies of Systemic Lupus Erythematosus

Lupus is an autoimmune disease characterized by inflammation of different tissues of the body. The most common type of lupus is systemic lupus erythematosus (SLE), which affects different parts of the body including internal organs. The causes of SLE are unknown but are believed to be linked to genetic, environmental, and hormonal factors. Women of childbearing ages are at greatest risk of developing SLE.

The NIAID role in lupus research includes supporting clinical trials that are conducted across the United States. The following study is sponsored by NIAID. The link leads to a full description, eligibility criteria, and contact information.

JBT-101 in Systemic Lupus Erythematosus (NCT03093402)
This clinical trial evaluates JBT-101 to resolve innate immune responses without immunosuppression in people with Lupus ages 18 to 70 years.

 

Contact Information

For questions about participating in this clinical study, contact

Office of Patient Recruitment
Toll Free: 1-800-411-1222
TTY: 1-866-411-1010
Se habla español.
Email: prpl@mail.cc.nih.gov

Content last reviewed on

Participating in Research

Watch a series of short informational videos about participating in clinical trials. These videos are intended to help potential participants understand how research works, what questions they should consider asking, and things to think about when deciding whether or not to participate in a study.